Recruiting Parkinsons Disease Studies in Cullman
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
This study will evaluate the effect of triple ICS/LAMA/LABA therapy with BGF MDI 320/14.4/9.6 μg on cardiopulmonary outcomes relative to LAMA/LABA therapy with GFF MDI 14.4/9.6 μg in a population with...
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive...
About Parkinsons Disease Clinical Trials in Cullman
Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.
There are currently 2 parkinsons disease clinical trials recruiting participants in Cullman, ALABAMA. These studies are seeking a combined 5,990 participants. Research is being sponsored by AstraZeneca. Clinical trial participation is free and participants receive study-related medical care at no cost.
Parkinsons Disease Clinical Trials in Cullman — FAQ
Are there parkinsons disease clinical trials in Cullman?
Yes, there are 2 parkinsons disease clinical trials currently recruiting in Cullman, ALABAMA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Cullman?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cullman research site will contact you about next steps.
Are clinical trials in Cullman free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cullman studies also compensate for your time and travel.
What parkinsons disease treatments are being tested?
The 2 active trials in Cullman are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.
Data updated March 2, 2026 from ClinicalTrials.gov